Jian Zhang

机构：Shanghai Medical College of Fudan University, Harbin Medical University, Sun Yat-sen University, Shanghai Jiao Tong University, Shaoxing University, Ruijin Hospital, Fudan University Shanghai Cancer Center, Third Affiliated Hospital of Harbin Medical University, The First Affiliated Hospital, Sun Yat-sen University, Shaoxing People's Hospital · ORCID：0000-0003-3208-3106

发表论文 38 篇 · 总被引 636 次 · h-index 11

代表论文

• Phase I study of A166, an antibody‒drug conjugate in advanced HER2-expressing solid tumours (2023 · npj Breast Cancer · 被引 55)
• Apatinib plus vinorelbine versus vinorelbine for metastatic triple-negative breast cancer who failed first/second-line treatment: the NAN trial (2022 · npj Breast Cancer · 被引 31)
• MAGNIMS recommendations for harmonization of MRI data in MS multicenter studies (2022 · NeuroImage Clinical · 被引 27)
• 9MW2821, a nectin-4 antibody-drug conjugate (ADC), in patients with advanced solid tumor: Results from a phase 1/2a study. (2024 · Journal of Clinical Oncology · 被引 18)
• PDGFD induces ibrutinib resistance of diffuse large B‑cell lymphoma through activation of EGFR (2020 · Molecular Medicine Reports · 被引 15)
• GSTT1, GSTP1, and GSTM1 genetic variants are associated with survival in previously untreated metastatic breast cancer (2017 · Oncotarget · 被引 14)